Thermo Fisher to Buy Back $750M in Stock | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that its board of directors has approved the repurchase of $750 million of the firm's common stock on the open market or through negotiated transactions.

The firm said that the purchase authorization will remain in effect through Nov. 9, 2012. As of today, it has $25 million remaining under an existing share repurchase program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.